Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae

Calvo, AlmudenaGiménez, María JoséAlou Cervera, LuisGómez-Lus Centelles, María LuisaAguilar, LorenzoPrieto Prieto, José2024-07-242024-07-242002-08Calvo A, Giménez MJ, Alou L, Gómez-Lus ML, Aguilar L, Prieto J. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae. Int J Antimicrob Agents. 2002 Aug;20(2):144-6.0924-857910.1016/s0924-8579(02)00119-xhttps://hdl.handle.net/20.500.14352/107072engEx vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniaejournal articlehttps://doi.org/10.1016/S0924-8579(02)00119-Xhttps://www.sciencedirect.com/science/article/pii/S092485790200119Xrestricted access611.02Ex vivo activityKilling ratesGemifloxacinStreptococcus pneumoniaeMicrobiología médica2414 Microbiología